FT Options’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-5,740
Closed -$379K 95
2017
Q1
$379K Buy
+5,740
New +$379K 0.5% 43
2016
Q4
Hold
0
130
2016
Q3
Sell
-13,573
Closed -$1.01M 146
2016
Q2
$1.01M Buy
13,573
+12,188
+880% +$907K 0.87% 21
2016
Q1
$93K Buy
+1,385
New +$93K 0.1% 57